Literature DB >> 28070162

Contrast-Enhanced Ultrasonography in Evaluation of the Therapeutic Effect of Chemotherapy for Patients with Liver Metastases.

Naoyuki Ueda1, Haruki Nagira1, Naoko Sannomiya1, Saeko Ikunishi1, Yuiko Hattori1, Akira Kamida1, Yuki Koyanagi1, Kenta Shimabayashi1, Kengo Sato1, Hiroaki Saito2, Yasuaki Hirooka1.   

Abstract

BACKGROUND: The therapeutic effect of chemotherapy for liver metastases is currently determined by changes in tumor diameter depicted on computed tomography (CT) and magnetic resonance imaging, but it cannot accurately determine if there is central necrosis. Furthermore, due to the risk of radiation exposure and high cost, frequent examination using these methods places a heavy burden on patients. Meanwhile, real-time observation of blood flow and vessel morphology within tumors has become possible by contrast-enhanced ultrasonography (CEUS). However, use of CEUS in evaluating the therapeutic effect of anticancer chemotherapy has rarely been investigated. This study investigated whether changes in the time-intensity curve (TIC) of CEUS are useful indicators of the therapeutic effect of chemotherapy.
METHODS: Five patients with liver metastases who had undergone CEUS before and after chemotherapy were included in this study. The TIC of each time point was prepared to examine whether the following five TIC parameters serve as indicators of the therapeutic effect of chemotherapy: peak intensity, time to wash-in, time to peak intensity, slope of wash-in, and area under the curve. In each parameter, rate of change (ROC) was calculated by the expression [(values before chemotherapy minus those after chemotherapy)/those before chemotherapy × 100(%)].
RESULTS: (i) Among the five TIC parameters tested, ROC of the slope of wash-in and the area under the curve reflected the therapeutic effect of chemotherapy better than the remaining three parameters. (ii) TIC parameters after one cycle of chemotherapy were examined in two of five patients, and changes in the slope of wash-in and the area under the curve were in good agreement with the computed tomography findings indicative of the therapeutic effect after the fourth chemotherapy cycle.
CONCLUSION: The findings of this study suggest that ROC of the slope of wash-in and the area under the curve of the TIC are useful in evaluating the therapeutic effect of chemotherapy. Furthermore, there is a possibility that TIC analysis may enable early prediction of the therapeutic effect.

Entities:  

Keywords:  Sonazoid; liver; neoplasm metastases; time intensity curve; ultrasonography

Year:  2016        PMID: 28070162      PMCID: PMC5214691     

Source DB:  PubMed          Journal:  Yonago Acta Med        ISSN: 0513-5710            Impact factor:   1.641


  16 in total

1.  Response evaluation of chemotherapy in metastatic colorectal cancer by contrast enhanced ultrasound.

Authors:  Ramin Schirin-Sokhan; Ron Winograd; Christoph Roderburg; Jhenee Bubenzer; Nicole Cabral do Ó; Dorothee Guggenberger; Hartmut Hecker; Christian Trautwein; Jens J W Tischendorf
Journal:  World J Gastroenterol       Date:  2012-02-14       Impact factor: 5.742

2.  Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS.

Authors:  Michel Claudon; Christoph F Dietrich; Byung Ihn Choi; David O Cosgrove; Masatoshi Kudo; Christian P Nolsøe; Fabio Piscaglia; Stephanie R Wilson; Richard G Barr; Maria C Chammas; Nitin G Chaubal; Min-Hua Chen; Dirk Andre Clevert; Jean Michel Correas; Hong Ding; Flemming Forsberg; J Brian Fowlkes; Robert N Gibson; Barry B Goldberg; Nathalie Lassau; Edward L S Leen; Robert F Mattrey; Fuminori Moriyasu; Luigi Solbiati; Hans-Peter Weskott; Hui-Xiong Xu
Journal:  Ultrasound Med Biol       Date:  2012-11-05       Impact factor: 2.998

3.  Advanced Hepatocellular Carcinoma: early evaluation of response to targeted therapy and prognostic value of Perfusion CT and Dynamic Contrast Enhanced-Ultrasound. Preliminary results.

Authors:  Eric Frampas; Nathalie Lassau; Magaly Zappa; Marie-Pierre Vullierme; Serge Koscielny; Valérie Vilgrain
Journal:  Eur J Radiol       Date:  2012-12-28       Impact factor: 3.528

Review 4.  Dynamic contrast-enhanced ultrasonography (DCE-US): a new tool for the early evaluation of antiangiogenic treatment.

Authors:  Nathalie Lassau; Mohamed Chebil; Linda Chami; Sophie Bidault; Elizabeth Girard; Alain Roche
Journal:  Target Oncol       Date:  2010-04-09       Impact factor: 4.493

Review 5.  Liver metastases: Contrast-enhanced ultrasound compared with computed tomography and magnetic resonance.

Authors:  Vito Cantisani; Hektor Grazhdani; Cristina Fioravanti; Maria Rosignuolo; Fabrizio Calliada; Daniela Messineo; Maria Giulia Bernieri; Adriano Redler; Carlo Catalano; Ferdinando D'Ambrosio
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

6.  Advanced hepatocellular carcinoma: early evaluation of response to bevacizumab therapy at dynamic contrast-enhanced US with quantification--preliminary results.

Authors:  Nathalie Lassau; Serge Koscielny; Linda Chami; Mohamed Chebil; Baya Benatsou; Alain Roche; Michel Ducreux; David Malka; Valérie Boige
Journal:  Radiology       Date:  2010-10-27       Impact factor: 11.105

Review 7.  Update on the role of imaging in management of metastatic colorectal cancer.

Authors:  Sree Harsha Tirumani; Kyung Won Kim; Mizuki Nishino; Stephanie A Howard; Katherine M Krajewski; Jyothi P Jagannathan; James M Cleary; Nikhil H Ramaiya; Atul B Shinagare
Journal:  Radiographics       Date:  2014 Nov-Dec       Impact factor: 5.333

8.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

Authors:  E A Eisenhauer; P Therasse; J Bogaerts; L H Schwartz; D Sargent; R Ford; J Dancey; S Arbuck; S Gwyther; M Mooney; L Rubinstein; L Shankar; L Dodd; R Kaplan; D Lacombe; J Verweij
Journal:  Eur J Cancer       Date:  2009-01       Impact factor: 9.162

9.  Evaluation of the hemodynamic status of focal hepatic lesions 20 mm or less in diameter by contrast-enhanced ultrasonography using Sonazoid.

Authors:  Kazue Shiozawa; Manabu Watanabe; Yasukiyo Sumino
Journal:  Intervirology       Date:  2009-06-26       Impact factor: 1.763

10.  Validation of dynamic contrast-enhanced ultrasound in predicting outcomes of antiangiogenic therapy for solid tumors: the French multicenter support for innovative and expensive techniques study.

Authors:  Nathalie Lassau; Julia Bonastre; Michèle Kind; Valérie Vilgrain; Joëlle Lacroix; Marie Cuinet; Sophie Taieb; Richard Aziza; Antony Sarran; Catherine Labbe-Devilliers; Benoit Gallix; Olivier Lucidarme; Yvette Ptak; Laurence Rocher; Louis-Michel Caquot; Sophie Chagnon; Denis Marion; Alain Luciani; Sylvaine Feutray; Joëlle Uzan-Augui; Benedicte Coiffier; Baya Benastou; Serge Koscielny
Journal:  Invest Radiol       Date:  2014-12       Impact factor: 6.016

View more
  2 in total

1.  Accelerated Clearance of Ultrasound Contrast Agents Containing Polyethylene Glycol is Associated with the Generation of Anti-Polyethylene Glycol Antibodies.

Authors:  Samantha M Fix; A Gloria Nyankima; Morgan D McSweeney; James K Tsuruta; Samuel K Lai; Paul A Dayton
Journal:  Ultrasound Med Biol       Date:  2018-03-27       Impact factor: 2.998

2.  Diagnostic Performance of Contrast-Enhanced Ultrasound in Renal Cancer: A Meta-Analysis.

Authors:  Ke-Hao Pan; Li Jian; Wei-Jun Chen; Abdul Aziz Nikzad; Fang Q Kong; Xu Bin; Ya-Li Wang; Ming Chen
Journal:  Front Oncol       Date:  2020-11-18       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.